| |
| |
|
| Insider
Information: |
Mohr Erich |
| Relationship: |
Director |
| City: |
Mclean |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
353,132 |
|
|
Indirect Shares
|
144,713 |
|
|
| Direct
Value |
$691 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
497,845 |
|
|
| Total
Value |
$691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pra International |
PRAI |
EVP and Chief Scientif... |
2005-12-19 |
344,910 |
2005-12-19 |
144,713 |
Premium* |
|
|
Kintara Therapeutics, Inc |
KTRA |
Director |
2018-03-30 |
8,222 |
2016-07-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2018-03-30 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
8,222 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-12-31 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
7,694 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-09-29 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
7,166 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-06-30 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
6,638 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-06-26 |
4 |
B |
$3.60 |
$15,001 |
D/D |
4,167 |
6,110 |
2.39 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2017-03-31 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
1,943 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2016-12-31 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
1,415 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2016-10-03 |
4 |
A |
$3.20 |
$1,690 |
D/D |
528 |
887 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
Director |
– • – |
2016-07-18 |
4 |
A |
$3.20 |
$1,149 |
D/D |
359 |
359 |
0 |
- |
|
| PRAI |
Pra International |
officerTitle |
• – – |
2005-12-19 |
4 |
OE |
$6.56 |
$276,875 |
D/D |
18,500 |
344,910 |
|
- |
|
| PRAI |
Pra International |
officerTitle |
• – – |
2005-12-02 |
4/A |
S |
$28.50 |
$1,425,000 |
D/D |
(50,000) |
326,410 |
|
- |
|
| PRAI |
Pra International |
officerTitle |
• – – |
2005-12-02 |
4/A |
OE |
$6.56 |
$328,125 |
D/D |
50,000 |
376,410 |
|
- |
|
| PRAI |
Pra International |
officerTitle |
• – – |
2005-12-02 |
4 |
S |
$28.50 |
$1,425,000 |
D/D |
(50,000) |
276,410 |
|
- |
|
| PRAI |
Pra International |
EVP and Chief Scientific Off. |
• – – |
2005-06-20 |
4 |
S |
$23.50 |
$3,969,150 |
I/I |
(168,900) |
144,713 |
|
- |
|
| PRAI |
Pra International |
EVP and Chief Scientific Off. |
• – – |
2004-11-23 |
4 |
S |
$19.00 |
$1,157,765 |
I/I |
(60,935) |
313,613 |
|
- |
|
| PRAI |
Pra International |
EVP and Chief Scientific Off. |
• – – |
2004-11-23 |
4 |
S |
$19.00 |
$1,205,018 |
D/D |
(63,422) |
326,410 |
|
- |
|
| PRAI |
Pra International |
EVP and Chief Scientific Off.O |
• – – |
2004-11-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
374,548 |
|
- |
|
| PRAI |
Pra International |
EVP and Chief Scientific Off.O |
• – – |
2004-11-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
389,832 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
